Valuation: Vitrolife AB

Market Cap 1.25TCr 125.8Cr 110.64Cr 104.62Cr 95Cr 178.21Cr 12TCr 179.25Cr 483.79Cr 6.16TCr 472.29Cr 462.06Cr 20TCr P/E 2026 *
25.4x
P/E 2027 * 20.6x
Enterprise Value 1.31TCr 131.31Cr 115.49Cr 109.21Cr 99Cr 186.02Cr 13TCr 187.1Cr 504.99Cr 6.43TCr 492.99Cr 482.32Cr 21TCr EV / Sales 2026 *
3.78x
EV / Sales 2027 * 3.37x
Free-Float
54.39%
Yield 2026 *
1.2%
Yield 2027 * 1.36%
1 day-0.75%
1 week+1.09%
Current month-2.48%
1 month-4.00%
3 months+3.18%
6 months+0.54%
Current year-32.48%
1 week 91.65
Extreme 91.65
95.65
1 month 88.8
Extreme 88.8
96.7
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%+1.09%-28.35%-35.04% 127.26Cr
+0.05%+1.99%+195.40%+489.92% 2.38TCr
+3.26%+11.88%+655.12%+114.55% 1.12TCr
+2.57%+10.24%-29.47%-9.98% 1.04TCr
-0.72%+3.59%+8.77% - 903.74Cr
0.00%-0.54%+97.08%+43.45% 651.03Cr
+3.94%+1.37%-27.39%-22.39% 558.67Cr
0.00%+3.47%+6.93%-6.51% 444.51Cr
-4.05%-4.73%+53.55%+58.74% 385.51Cr
+1.43%+6.09%-13.29%-26.52% 286.44Cr
Average +0.57%+2.87%+91.84%+67.36% 789.46Cr
Weighted average by Cap. +0.85%+3.24%+156.79%+186.86%

Financials

2026 *2027 *
Net sales 345.76Cr 35Cr 31Cr 29Cr 26Cr 49Cr 3.33TCr 49Cr 133.54Cr 1.7TCr 130.36Cr 127.54Cr 5.47TCr 370.72Cr 37Cr 33Cr 31Cr 28Cr 53Cr 3.57TCr 53Cr 143.18Cr 1.82TCr 139.77Cr 136.75Cr 5.86TCr
Net income 49Cr 4.95Cr 4.35Cr 4.11Cr 3.73Cr 7.01Cr 474.77Cr 7.05Cr 19Cr 242.27Cr 19Cr 18Cr 778.52Cr 61Cr 6.11Cr 5.38Cr 5.08Cr 4.61Cr 8.66Cr 586.82Cr 8.71Cr 24Cr 299.44Cr 23Cr 22Cr 962.24Cr
Net Debt 55Cr 5.51Cr 4.85Cr 4.59Cr 4.16Cr 7.81Cr 529.27Cr 7.86Cr 21Cr 270.07Cr 21Cr 20Cr 867.87Cr -2.67Cr -26.85L -23.62L -22.33L -20.25L -38.04L -26Cr -38.26L -1.03Cr -13Cr -1.01Cr -98.63L -42Cr
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
28/26/28 SEK 92.50 -0.75% 65,602
25/26/25 SEK 93.20 -0.59% 71,013
24/26/24 SEK 93.75 -1.06% 58,816
23/26/23 SEK 94.75 +2.10% 1,99,568
22/26/22 SEK 92.80 +0.76% 1,63,064
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
92.50SEK
Average target price
129.60SEK
Spread / Average Target
+40.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock